Table 2.
Pre-protocol | Post-protocol | |
---|---|---|
Total patients | 733 | 158 |
Male | 421 (57%) | 88 (43%) |
Female | 312 (43%) | 70 (44%) |
Trisomy 21 | 87 (12%) | 22 (14%) |
22q11.2 deletion syndrome | 28 (4%) | 8 (5%) |
Tested with one of 3 target tests | 441 (60%) | 121 (77%) |
Karyotype | 307 (42%) | 33 (21%) |
22q11.2 deletion testing | 243 (33%) | 23 (15%) |
Microarray | 292 (40%) | 94 (59%) |
Untested patients | 292 (40%) | 37 (23%) |